Rewriting Women's Health
Rewriting Women’s Health spotlights the science, technology, and investment needed to close gaps in chronic conditions that differently and disproportionately affect women. For this inaugural summit, we are focusing on cardiovascular, autoimmune and neurological diseases. Researchers and innovators will discuss emerging technologies and innovations and how insights are being applied. Join fellow leaders across biotech, health tech, academia, clinical innovation and venture capital as we highlight NYC-based innovations in women's health.
AGENDA
1pm - Registration & Networking
1:30pm - Welcome / Opening Remarks
Reba Auslander, CEO, RAliance Communications
Sandy Polu, PhD, Founder, Alysia Health
Morgan Newman, CFP®, CDFA®, Director of Investments at Oppenheimer & Co. Inc.
1:40pm - Keynote: Public Sector Investment in Women's Health Innovation
Monica Malowney, MPH, Chief Careers and Industry Partnerships Officer, CUNY Beyond Program at CUNY Kingsborough Community College
2:00pm - Innovations to Address Sex Differences in Cardiovascular Disease
Suzanne Steinbaum, MD, CEO/Founder, Heart-Tech Health
Sahar Jalal, PhD, CEO/Founder, Lucentia
Moderator: Annette Pompa, President & Co-Founder, International Heart Spasms Alliance
2:40pm - Startup Pitches with Investor Feedback
Marie Onakomaiya, PhD, MPH, CEO, Metric Health
Gwendolyn von Rahn, Co-Founder & CEO, Sweetling Health
Vadim Gordin, GP, Mighty Middle Ventures
Mellie Chow, Founder & GP, Unapologetic Ventures
3:40pm - Emerging Technologies in Autoimmune Diseases
Shruti Naik, PhD, Director, Colton Center for Autoimmunity, and Professor, Icahn School of Medicine at Mt. Sinai
Irina Leonardi, PhD, Associate Director, Immunai
Moderator: Sandy Polu, PhD, Founder, Alysia Health
4:20pm - Innovations in Neurological Disorders
Justine Kupferman, PhD, Director of Neuroscience, TriGemX Bio
Moderator: Leslie Cohen, Executive Director, HERHealthEQ
5-6:00pm - Closing Remarks & Networking Cocktail